Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Probiotics are widely studied as a potential treatment for Irritable Bowel Syndrome (IBS). Multiple randomized controlled trials and meta-analyses have evaluated the efficacy of various probiotic strains in alleviating IBS symptoms such as bloating, abdominal pain, and altered bowel habits. The evidence suggests that certain probiotic strains, particularly from the genera Lactobacillus and Bifidobacterium, may provide modest benefit for some patients with IBS, especially in improving global symptoms and quality of life.

However, the strength of the evidence is limited by heterogeneity in study design, probiotic strains, dosages, and endpoints. Meta-analyses (e.g., Ford et al., 2018; Didari et al., 2015) conclude that while probiotics as a group appear to be more effective than placebo in reducing IBS symptoms, the effect size is moderate, and not all probiotics are equally effective. There is insufficient evidence to recommend any specific strain or formulation. Guidelines from organizations such as the American College of Gastroenterology acknowledge the possible benefit but emphasize that individual response may vary and more research is needed to clarify optimal strains and dosing.

In summary, the use of probiotics for IBS is supported by a moderate level of scientific evidence, with some benefit demonstrated for certain strains, but with significant uncertainty regarding the most effective formulations and long-term effects.

More about Probiotic (unspecified)
More about Irritable Bowel Syndrome

Other ingredients used for Irritable Bowel Syndrome

Other health conditions supported by Probiotic (unspecified)

Products containing Probiotic (unspecified)